Visceral leishmaniasis with cutaneous and rectal dissemination due to Leishmania braziliensis in acquired immunodeficiency syndrome (AIDS).
Hernández
D E
DE
Department of Medicine, Hospital Vargas, School of Medicine, Universidad Central de Venezuela, Caracas.
Oliver
M
M
Martínez
C
C
Planas
G
G
D017088:AIDS-Related Opportunistic Infections / Q000175:diagnosis / Q000188:drug therapy; D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000276:immunology; D000328:Adult; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D007892:Leishmania braziliensis / Q000302:isolation & purification*; D016773:Leishmaniasis, Cutaneous / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D007898:Leishmaniasis, Visceral / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D008297:Male; D008536:Meglumine / Q000627:therapeutic use; D000077485:Meglumine Antimoniate; D009942:Organometallic Compounds / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000627:therapeutic use; D012002:Rectal Diseases / Q000150:complications / Q000382:microbiology
D000970:Antineoplastic Agents; D000981:Antiprotozoal Agents; D009942:Organometallic Compounds; D011994:Recombinant Proteins; D008536:Meglumine; D000077485:Meglumine Antimoniate; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; C082430:molgramostim